NCT06153251 2026-03-18A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple MyelomaJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyPhase 1 Recruiting187 enrolled
NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT06241456 2025-12-09FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Recruiting351 enrolled